|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.600 CNY | +2.22% |
|
-2.54% | -11.88% |
| Market Cap | 6.52B 963M 847M 788M 724M 1.36B 92.36B 1.38B 9.37B 3.66B 45.61B 3.62B 3.54B 158B | P/E 2024 |
18.2x | P/E 2025 | 29x |
|---|---|---|---|---|---|
| Enterprise Value | 5.03B 743M 653M 608M 558M 1.05B 71.25B 1.06B 7.23B 2.82B 35.18B 2.79B 2.73B 122B | EV / Sales 2024 |
0.62x | EV / Sales 2025 | 0.84x |
| Free-Float |
39.51% | Yield 2024 |
1.9% | Yield 2025 | 1.05% |
| 23-03-17 | China Monthly Antitrust Update - March 2023 | AQ |
| 1 day | +2.22% | ||
| 1 week | -2.54% | ||
| Current month | +8.49% | ||
| 1 month | +9.52% | ||
| 3 months | -7.82% | ||
| 6 months | -16.67% | ||
| Current year | -11.88% |
| 1 week | 4.47 |  | 4.77 |
| 1 month | 4.09 | | 4.94 |
| Current year | 4.09 | | 5.73 |
| 1 year | 4.09 | | 6.45 |
| 3 years | 3.72 | | 6.69 |
| 5 years | 3.72 | | 9.3 |
| 10 years | 3.72 | | 9.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Gang Cai
CEO | Chief Executive Officer | 46 | 2025-01-20 |
Xin Li
DFI | Director of Finance/CFO | 46 | 2025-09-05 |
Dong Sheng Yan
IRC | Investor Relations Contact | 42 | 2024-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Kai Zhou
CHM | Chairman | 62 | 2025-01-20 |
Xin Hua Ao
BRD | Director/Board Member | 62 | 2018-07-17 |
Cheng Ren Huang
BRD | Director/Board Member | 62 | 2018-07-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.22% | -2.54% | -29.12% | -13.37% | 969M | |
| +2.32% | +4.06% | +51.36% | +166.78% | 1,068B | |
| +2.75% | +8.95% | +64.26% | +56.49% | 641B | |
| +3.63% | +3.50% | +40.60% | +75.71% | 454B | |
| +2.25% | +9.83% | +40.68% | +36.08% | 351B | |
| +1.96% | +4.13% | +40.05% | +44.84% | 299B | |
| +1.38% | +4.42% | +20.89% | +17.96% | 266B | |
| +2.74% | +2.78% | -26.18% | -36.97% | 220B | |
| +5.40% | +7.52% | +30.70% | +66.60% | 203B | |
| +3.46% | +2.89% | +18.60% | +74.41% | 162B | |
| Average | +2.84% | +2.31% | +25.18% | +48.85% | 366.43B | |
| Weighted average by Cap. | +2.75% | +2.85% | +40.86% | +81.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.5B 1.11B 974M 907M 833M 1.56B 106B 1.58B 10.78B 4.21B 52.46B 4.16B 4.07B 181B | 7.07B 1.04B 918M 855M 785M 1.47B 100B 1.49B 10.16B 3.97B 49.47B 3.92B 3.84B 171B |
| Net income | 410M 60.52M 53.21M 49.53M 45.48M 85.41M 5.8B 86.54M 589M 230M 2.87B 227M 222M 9.91B | 260M 38.4M 33.76M 31.43M 28.86M 54.2M 3.68B 54.91M 374M 146M 1.82B 144M 141M 6.29B |
| Net Debt | -2.88B -425M -373M -348M -319M -599M -40.73B -607M -4.13B -1.61B -20.11B -1.59B -1.56B -69.5B | -1.49B -220M -193M -180M -165M -311M -21.11B -315M -2.14B -836M -10.42B -826M -808M -36.02B |
Employees
5,727
Sector
Pharmaceuticals
Calendar
Aug. 25
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | CN¥4.600 | +2.22% | 9,920,092 |
| 26-07-24 | CN¥4.500 | -4.26% | 12,149,082 |
| 26-07-23 | CN¥4.700 | +0.86% | 12,455,763 |
| 26-07-22 | CN¥4.660 | -0.43% | 13,679,391 |
| 26-07-21 | CN¥4.680 | -0.85% | 17,080,519 |
- Stock Market
- Stocks
- 000597 Stock
Select your edition
All financial news and data tailored to specific country editions
